Top

Published in:

01-12-2007 | ORIGINAL PAPER

Controversies in ammonia metabolism: implications for hepatic encephalopathy

Author: Alan H. Lockwood

Published in: Metabolic Brain Disease | Issue 3-4/2007

Excerpt

There have almost always been controversial aspects concerning the role of ammonia in the production of hepatic encephalopathy (HE). This was true 50 years ago and is certainly true now. This review will address some of these controversies. …

Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Kostler H, Hecker H, Burchert W (2004). Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79PubMedCrossRef

Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, Bower RH, Mabry CD, Leevy CM, Kiernan T (1985) Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr 9:288–295PubMed

Cooper AJ, McDonald JM, Gelbard AS, Gledhill RF, Duffy TE (1979) The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 254:4982–4992PubMed

Eriksson LS, Conn HO (1989) Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology 10:228–246PubMedCrossRef

Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F (1974) Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 127:40–47PubMedCrossRef

Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB (1976) The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77–91PubMed

Gjedde A, Lockwood AH, Duffy TE, Plum F (1978) Cerebral blood flow and metabolism in chronically hyperammonemic rats: effect of an acute ammonia challenge. Ann Neurol 3:325–330PubMedCrossRef

Gratton JA, Abraham MH, Bradbury MW, Chadha HS (1997) Molecular factors influencing drug transfer across the blood–brain barrier. J Pharm Pharmacol 49:1211–1216PubMed

Harmar AJ, Horn AS (1976) Octopamine in mammalian brain: rapid post mortem increase and effects of drugs. J Neurochem 26:987–993PubMedCrossRef

Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 43:42–50PubMedCrossRef

Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, Plum F (1979) The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 63:449–460PubMedCrossRef

Lockwood AH, Finn RD, Campbell JA, Richman TB (1980) Factors that affect the uptake of ammonia by the brain: the blood–brain pH gradient. Brain Res 181:259–266PubMedCrossRef

Lockwood AH, Yap EW, Wong WH (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 11:337–341PubMed

Michel H, Solere M, Granier P, Cauvet G, Bali JP, Pons F, Bellet-Herman H (1980) Treatment of cirrhotic hepatic encephalopathy with L-DOPA, a controlled trial. Gastroenterology 79:207PubMed

Michel H, Bories P, Aubin JP, Pomier Layrargues G, Bauret P, Bellet Herman H (1985) Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients. Liver 5:282–289PubMed

Phelps ME, Hoffman EJ, Raybaud C (1977) Factors which affect cerebral uptake and retention of ¹³NH3. Stroke 8:694–702PubMed

Raichle ME, Larson KB (1981) The significance of the NH₃–\( {\text{NH}}^{{\text{ + }}}_{{\text{4}}} \) equilibrium on the passage of ¹³N–ammonia from blood to brain. Circ Res 48:913–937PubMed

Sørensen M, Keiding S (2006) Response to Lockwood and Wack: The brain permeability-surface product for ammonia. Hepatology 43:1053–1056CrossRef

Uribe M, Garcia-Ramos G, Ramos M, Valverde C, Marquez MA, Farca A, Guevara L (1983) Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy. Am J Gastroenterol 78:517–522PubMed

Wahren K, Denis J, Desurmont P, Eriksson LS, Escoffier J-M, Gauthier AP, Hagenfeldt L, Michel H, Opolon P, Paris J-C, Veyrac M (1983) Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 3:475–480PubMedCrossRef

Zieve L, Olsen RL (1977) Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? Gut 18:688–691PubMedCrossRef

Title: Controversies in ammonia metabolism: implications for hepatic encephalopathy
Author: Alan H. Lockwood
Publication date: 01-12-2007
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 3-4/2007
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-007-9059-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Controversies in ammonia metabolism: implications for hepatic encephalopathy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3-4/2007

Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction

The treatment of hepatic encephalopathy

Aquaporin-4 in hepatic encephalopathy

The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy

Therapeutic studies in hepatic encephalopathy

Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension